NeoGenomics, Inc.
| Security | NEO / NeoGenomics, Inc. |
| Insider | Kathryn B McKenzie |
This page shows the track record and history of McKenzie Kathryn B
insider trades in NeoGenomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Kathryn B McKenzie in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Kathryn B McKenzie in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-10 | 8,000 | 26.3700 | 8,000 | 26.3700 | 210,960 | 97 | 20.5 | -46,960 | -22.26 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-12 | 2022-01-11 | 4 | McKenzie Kathryn B | NEO | Stock Option (Right to Buy) | D | 9.07 | -2,100 | 17,900 | |||||
| 2022-01-12 | 2022-01-11 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 9.0700 | 2,100 | 19 | 49,361 | ||||
| 2021-12-30 | 2021-12-30 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 30,572 | 47,261 | ||||||
| 2021-12-23 | 2021-12-22 | 4 | McKenzie Kathryn B | NEO | Stock Option (Right to Buy) | D | 9.07 | -5,000 | 20,000 | |||||
| 2021-12-23 | 2021-12-22 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 9.0700 | 5,000 | 45 | 16,689 | ||||
| 2021-12-23 | 2021-12-21 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 35.0000 | -1,846 | -65 | 11,689 | ||||
| 2021-03-03 | 2021-03-02 | 4 | McKenzie Kathryn B | NEO | Stock Option (Right to Buy) | D | 53.17 | 53.1700 | 35,171 | 1,870 | 35,171 | |||
| 2021-03-03 | 2021-03-02 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 6,207 | 13,535 | ||||||
| 2021-03-03 | 2021-03-02 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | -432 | 7,328 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | -169 | 7,760 | ||||||
| 2020-03-03 | 2020-03-02 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 28.33 | 28.3300 | 37,514 | 1,063 | 37,514 | |||
| 2020-03-03 | 2020-03-02 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 5,824 | 7,929 | ||||||
| 2020-03-03 | 2020-03-01 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | -168 | 2,105 | ||||||
| 2019-12-12 | 2019-12-10 | 4 | McKenzie Kathryn B | NEO | Stock Option (Right to Buy) | D | 8.03 | -8,000 | 40,000 | |||||
| 2019-12-12 | 2019-12-10 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 26.3700 | -8,000 | -211 | 2,273 | ||||
| 2019-12-12 | 2019-12-10 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 8.0300 | 8,000 | 64 | 10,273 | ||||
| 2019-03-05 | 2019-03-01 | 4 | McKenzie Kathryn B | NEO | Stock Option (Right to Buy) | D | 19.60 | 19.6000 | 13,894 | 272 | 13,894 | |||
| 2019-03-05 | 2019-03-01 | 4 | McKenzie Kathryn B | NEO | Common Stock | D | 2,273 | 2,273 | ||||||
| 2018-02-28 | 2018-02-26 | 4 | McKenzie Kathryn B | NEO | Stock Option (Right to Buy) | D | 8.03 | 8.0300 | 48,000 | 385 | 48,000 | |||
| 2017-10-20 | 2017-10-18 | 4 | McKenzie Kathryn B | NEO | Stock Option (Right to Buy) | D | 9.07 | 9.0700 | 25,000 | 227 | 25,000 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
